The Economics of Medical Decision Making

Stefan Felder () and Thomas Mayrhofer ()
Additional contact information
Stefan Felder: University of Basel
Thomas Mayrhofer: Stralsund University of Applied Sciences

Chapter Chapter 10 in Medical Decision Making, 2022, pp 209-231 from Springer

Abstract: Abstract We present the economics of medical decision making, taking into consideration that every decision has opportunity cost. Money spent on health is no longer available for other purposes. Like benefits and harms, the costs of medical services influence the test and treatment thresholds and will affect medical decisions. We study two versions. The QALY approach includes only health in the decision makers’ utility function. Commensurability between the utility gain and utility loss of treatment, and its cost is achieved by defining a willingness to pay for a QALY. The more general approach, which is referred to as welfarism, assumes that utility of health and utility of consumption are not separable but rather mutually dependent. We study the implications of test and treatment costs for the thresholds in the decisions under diagnostic and therapeutic risks.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-662-64654-0_10

Ordering information: This item can be ordered from
http://www.springer.com/9783662646540

DOI: 10.1007/978-3-662-64654-0_10

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().